Browse studies, page 702
Page 702 of 1,298, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Sexual dysfunction in movement disorders: prevalence, clinical features, associated factors and management Clinical parkinsonism & related disorders, 2026
- Anterior ischemic optic neuropathy in patients treated with semaglutide: report of four cases with a possible association BMC ophthalmology, 2025
- Pulmonary arterial hypertension therapies in patients with obesity hypoventilation syndrome: a case series Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2025
- Successful interventional closure of patent ductus arteriosus in three pediatric cases with congenital heart disease and severe pulmonary hypertension: a case series and literature review Frontiers in cardiovascular medicine, 2025
- Altitude hypoxia and hypoxemia: pathogenesis and management Signal transduction and targeted therapy, 2026
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology Medicina (Kaunas, Lithuania), 2026
- Avanafil use in patients with erectile dysfunction and co-morbidities: Clinical insights from multiple aetiologies - A case series Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia, 2025
- Replantation following complete penile amputation: Summary of perioperative experience and treatment strategies Andrology, 2025
- Exploratory disproportionality analysis of potentially drug-induced eosinophilic pneumonia using United States Food and Drug Administration adverse event reporting system Scientific reports, 2025
- Diagnostic and management dilemmas in pulmonary hypertension European respiratory review : an official journal of the European Respiratory Society, 2026
- Direct prostacyclin transition in pediatric patients with pulmonary hypertension Pulmonary circulation, 2024
- Current and Evolving Concepts in the Management of Complex Regional Pain Syndrome: A Narrative Review Diagnostics (Basel, Switzerland), 2025
- Dasatinib-Associated Chylothorax: A Scoping Review and Pharmacovigilance Analysis Therapeutic innovation & regulatory science, 2026
- Risk stratification and multidisciplinary management strategies for pregnancy complicated by pulmonary arterial hypertension: a narrative review Frontiers in endocrinology, 2026
- Pediatric Pulmonary Hypertension Associated With Treatment of Myeloproliferative Disorders and Malignant Tumors Pulmonary circulation, 2025
- The choroid as a vascular sensor in pulmonary hypertension: an oculomic mini review Frontiers in cardiovascular medicine, 2026
- Hyperbaric Oxygen Therapy in the Management of Dermal Filler-Induced Vascular Occlusion: A Scoping Review The Journal of clinical and aesthetic dermatology, 2026
- Safety of Robotic-Assisted Bronchoscopy for Pulmonary Lesions in Patients With Pulmonary Hypertension on Vasodilator Therapy: A Single-Centre Experience Respirology case reports, 2025
- Pubovesical Complex-Sparing Under Hypothermia During Robotic-Assisted Laparoscopic Radical Prostatectomy: A Single-Institution Case Series Journal of clinical medicine, 2025
- The multidisciplinary management of pulmonary arterial hypertension patients in pregnancy and postpartum: A case series American heart journal plus : cardiology research and practice, 2025
- Dermatomyositis With Necrotizing Vasculitis, Pulmonary Arterial Hypertension, and Extensive Calcinosis Following Delayed Diagnosis Cureus, 2026
- Off-Label Sildenafil Citrate as a Rescue Therapy for Areolar Venous Congestion Post-Breast Reduction: Case Series and Outcomes Life (Basel, Switzerland), 2025
- Progressive Pericardial Effusions (PEF) in Patients With Pulmonary Arterial Hypertension (PAH) Taking Sotatercept-Association With Pre-Existing Pericardial Effusion Pulmonary circulation, 2025
- Erectile Dysfunction and Peyronie's Disease Following a Severe Case of COVID-19: A Case Report Case reports in urology, 2025
- Parenteral Treprostinil as an Effective Bridge to Lung Transplant in Patients with Severe Pulmonary Hypertension Associated with Interstitial Lung Disease Journal of cardiovascular development and disease, 2026
- Acute Postpartum Respiratory Distress With Right Ventricular Dysfunction Complicating Into Postpartum Cardiomyopathy: A Case of Suspected Atypical Amniotic Fluid Embolism Clinical case reports, 2026
- Sotatercept for the treatment of portopulmonary hypertension: a case report Communications medicine, 2026
- High-altitude pulmonary edema: a case series of four patients from Nepal Annals of medicine and surgery (2012), 2026
- Late Onset Pulmonary Arterial Hypertension Associated With Features of Pulmonary Veno-Occlusive Disease and Rare Heterozygous Variants of KDR and EIF2AK4 Pulmonary circulation, 2025
- The Role of Phosphodiesterase-5 Enzyme Inhibitors and Prostacyclin Analogs in Reactive Pulmonary Vasculopathy in Systolic Heart Failure: A Narrative Review Cureus, 2025
- A Case Series: Pericardial Effusion in Patients Treated With Sotatercept Pulmonary circulation, 2025
- Right Ventricular Function Improves With Pulmonary Vasodilator Treatment in Pediatric Patients With Pulmonary Hypertension and Multivessel Pulmonary Vein Stenosis in a Single Center Cohort Pulmonary circulation, 2026
- Ophthalmoplegia Caused by Non-Aneurysm Neurovascular Conflict: Clinical Cases of Eight Patients Revista de neurologia, 2026
- Low-Intensity Extracorporeal Shock Wave Therapy (LI-ESWT) for Erectile Dysfunction in Patients Post-prostatectomy: A Systematic Review Cureus, 2025
- An Early Single-Center Case Series Experience With a Recently Introduced Formulation of Inhaled Treprostinil (Yutrepia) Cureus, 2026
- Extracorporeal Life Support (ECLS) for Pulmonary Vein Stenosis Interventions Pediatric cardiology, 2026
- Use of Sotatercept to Facilitate Transition From Intravenous to Oral Prostacyclin Therapy The clinical respiratory journal, 2025
- Surgical management of autoimmune-associated calcinosis: a dermatomyositis case and case-based review Rheumatology international, 2026
- Methamphetamine-Associated Pulmonary Arterial Hypertension in a Japanese Pulmonary Hypertension Referral Center Circulation reports, 2026
- Sexual Dysfunction and Infertility in Male Patients With Spinal Cord Injury: A Narrative Review Cureus, 2026
- Presentations Due to Priapism in an Urban Hospital in Switzerland Emergency medicine international, 2026
- Pulmonary Veno-Occlusive Disease: A Focused Clinicopathologic Series Pulmonary circulation, 2026
- PDE5is-naïve versus non-naïve patients at first investigation for erectile dysfunction-findings from a long-term, real-life cross-sectional study Andrology, 2025
- Evaluating the management trends for priapism and assessing the risk of priapism after in-office intracavernosal injections: a cross-sectional analysis International journal of impotence research, 2025
- Recreational use of erectile dysfunction medications in undergraduate men in the United States: characteristics and associated risk factors Archives of sexual behavior, 2011
- Do baseline estrogen and testosterone affect lower urinary tract symptoms ( LUTS ) prior to or after pharmacologic treatment with tadalafil? Andrology, 2015
- Prescription opioids for back pain and use of medications for erectile dysfunction Spine, 2013
- The Global Online Sexuality Survey (GOSS): the United States of America in 2011 chapter II: phosphodiesterase inhibitors utilization among English speakers The journal of sexual medicine, 2013
- Importation of prescription medicines into New Zealand: a snapshot of intercepted products International journal of clinical pharmacy, 2011
- Community pharmacy detection of erectile dysfunction in men with risk factors or who seek treatment or advice but lack a valid prescription The journal of sexual medicine, 2013
- A United States Cross-Sectional Analysis of Annual Out-of-Pocket Cost Disparities of Erectile Dysfunction Medications Urology practice, 2025
- Multimodal rehabilitation for hard flaccid syndrome in a retrospective case series Frontiers in Rehabilitation Sciences, 2026
- Upadacitinib as a potential management option for diffuse cutaneous systemic sclerosis: A case report SAGE Open Medical Case Reports, 2025
- Clustering of tadalafil API samples according to their manufacturer in the context of API falsification detection Journal of Pharmacy and Science, 2023
- Clinical application of tadalafil in dogs with pulmonary hypertension: a retrospective study Korean Journal of Veterinary Research, 2026
- Ischemic priapism caused by self intracavernous injection of tadalafil IJU Case Reports, 2024
- Initial tadalafil and ambrisentan combination therapy in pulmonary arterial hypertension: cLinical and haemodYnamic long-term efficacy (ITALY study) Journal of cardiovascular medicine (Hagerstown, Md.), 2018
- Impact of tadalafil once daily in men with erectile dysfunction--including a report of the partners' evaluation Urology, 2010
- Evaluation of the efficacy of once-daily use of tadalafil vs. on-demand use. Is there a cumulative effect? JPMA. The Journal of the Pakistan Medical Association, 2012
- Role of tadalafil in enhancing visualization of posterior urethra prior to combined voiding cystourethrogram and retrograde urethrogram: a retrospective analysis Abdominal radiology (New York), 2021
- Transition of PH patients from sildenafil to tadalafil: feasibility and practical considerations Lung, 2012
- The association of tadalafil exposure with lower rates of major adverse cardiovascular events and mortality in a general population of men with erectile dysfunction Clinical cardiology, 2024
- Long-term effects of combination treatment comprising low-intensity extracorporeal shockwave therapy and tadalafil for patients with erectile dysfunction: a retrospective study International journal of impotence research, 2024
- Use of phosphodiesterase type 5 inhibitors in assistive living and home care settings Applied nursing research : ANR, 2015
- Impact of postoperative phosphodiesterase type 5 inhibitor treatment on lower urinary tract symptoms after robot-assisted radical prostatectomy: a longitudinal study Scandinavian journal of urology, 2017
- Safety and tolerability of combination therapy with ambrisentan and tadalafil for the treatment of pulmonary arterial hypertension in children: Real-world experience Pediatric pulmonology, 2022
- Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma JAMA, 2015
- Circulating endothelial progenitor cells and endothelial microparticles in patients with arterial erectile dysfunction and metabolic syndrome Journal of andrology, 2012
- Phosphodiesterase type 5 inhibitors improve microvascular dysfunction markers in pulmonary arterial hypertension associated with congenital heart disease Congenital heart disease, 2019
- Retrospective evaluation of the efficacy of daily paroxetine/tadalafil combination in patients with premature ejaculation and erectile dysfunction European review for medical and pharmacological sciences, 2023
- Treatment of erectile dysfunction in patients with plastic induration of the penis Urologiia (Moscow, Russia : 1999), 2008
- Phosphodiesterase inhibitors in the treatment of erectile dysfunction in spinal cord-injured men Spinal cord, 2007
- Low dose daily versus on-demand high dose tadalafil in diabetic patients with erectile and ejaculatory dysfunction International journal of impotence research, 2018
- Effects on sexual function in Japanese patients with benign prostatic hyperplasia upon switching from combination therapy with α1 blocker and dutasteride to combination therapy with tadalafil and dutasteride The aging male : the official journal of the International Society for the Study of the Aging Male, 2020
- Therapeutic potential of phosphodiesterase type 5 inhibitors in heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension International journal of cardiology, 2019
- Retrospective analysis of the efficacy and safety of once-daily tadalafil in patient subgroups: men with mild vs moderate ED and aged <50 vs 50 years International journal of impotence research, 2013
- Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levels Clinical endocrinology, 2004
- Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension Chest, 2020
- Undertreatment of overactive bladder among men with lower urinary tract symptoms in the United States: A retrospective observational study Neurourology and urodynamics, 2020
- Acute effect of phosphodiesterase type 5 inhibitor on serum oxidative status and prolidase activities in men with erectile dysfunction Clinics (Sao Paulo, Brazil), 2010
- An evaluation of an alternative dosing regimen with tadalafil, 3 times/week, for men with erectile dysfunction: SURE study in 14 European countries European urology, 2005
- Phosphodiesterase Type-5 Inhibitor Prescription Patterns in the United States Among Men With Erectile Dysfunction: An Update The journal of sexual medicine, 2020
- Effects of Tadalafil 5 mg Dosed Once Daily in Men with Premature Ejaculation Urologia internationalis, 2017
- Plasma Drug Concentrations in Patients with Pulmonary Arterial Hypertension on Combination Treatment Respiration; international review of thoracic diseases, 2017
- Sudden hearing loss from PDE-5 inhibitors: A possible cellular stress etiology The Laryngoscope, 2009
- Erectile function after cystectomy with neurovascular preservation Actas urologicas espanolas, 2013
- Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study BMC pulmonary medicine, 2015
- The VO(2)-on kinetics in constant load exercise sub-anaerobic threshold reflects endothelial function and dysfunction in muscle microcirculation Physiological research, 2015
- Central serous chorioretinopathy and phosphodiesterase-5 inhibitors: a case-control postmarketing surveillance study Retina (Philadelphia, Pa.), 2010
- A comparison of different oral therapies versus no treatment for erectile dysfunction in 196 radical nerve-sparing radical prostatectomy patients International journal of impotence research, 2015
- Efficacy of tamsulosin and tadalafil in relieving benign prostatic hyperplasia related symptoms: A randomized double blind placebo controlled cross-over study Indian Journal of Urology, 2019
- Role of Serum High-Sensitivity C-Reactive Protein as a Predictor of Therapeutic Response to Tadalafil in Patients With Erectile Dysfunction: A Prospective Observational Study Journal of Sexual Medicine, 2019
- Tadalafil Improves Nocturia and Nocturia-Related Quality of Life in Patients with Benign Prostatic Hyperplasia (KYU-PRO Study) Urologia internationalis, 2020
- Effect of tamsulosin versus tamsulosin plus tadalafil on renal calculus clearance after shock wave lithotripsy: An open-labelled, randomised, prospective study Asian Journal of Urology, 2021
- Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study Respirology (Carlton South. Print), 2022
- Real-World Outcomes and Safety of Testosterone Therapy: A Longitudinal, Retrospective Cohort Study of Over 9,000 Men The World Journal of Men's Health, 2026
- (200) Real-World Effectiveness and Safety of Treatment for Testosterone Deficiency: A Cohort Study of Men Stratified by Baseline Testosterone Profiles Journal of Sexual Medicine, 2025
- PIH21 influence of concomitant diseases on the clinical response to treatment for erectile dysfunction 2006
- The economic effect of switching from sildenafil to another phosphodiesterase type 5 inhibitor Managed care interface, 2006
- Role of Phosphodiesterase Inhibitors in Improving Urodynamic Parameters in Patients with Spinal Cord Injury: A Preliminary Report Indian Journal of Neurosurgery, 2020
